Upcoming event Inflammaging in Clinical Practice: A one-day in-person event for clinicians & researchers - turn chronic inflammation data into action. Hosted within ISABS and Mayo Clinic. Register now.
Futuristic medical interface showing a digital hormone dashboard with body silhouette, data charts, and biological graphics on a translucent screen in a clinical lab environment.

GLYCANAGE FOR HORMONE TRACKING

The Next Gen Biomarker for Hormone Tracking

Understand how your hormones uniquely influence inflammation, immunity and cardiovascular risk to guide personalized hormone therapies.

Learn more
Join the waitlist arrow forward icon

30+ years of research

300,000+ samples analyzed

350+ scientific publications

Recognized by Leading Universities and Renowned Journals

  • University of Cambridge
  • Harvard University
  • Johns Hopkins University
  • King’s College London
  • University of Oxford
  • Yale University
  • Science Advances
  • Circulation Journal
  • Nature Communications
  • Gastroenterology Journal
  • Cell Press
  • Frontiers Journal
  • Diabetes Care Journal

THE CLINICAL CHALLENGE

Addressing a Major Clinical Blindspot

Hormone testing only reveals what’s in circulation—not its long-term biological impact on the body. Levels fluctuate daily, making it a poor tool for managing systemic health risks like chronic inflammation and immune aging.

GlycanAge fills this gap by quantifying the cumulative downstream effects of hormonal change, providing a stable, objective measure that guides precision therapy.
1

Identify the Major Clinical Blindspot

Standard hormone levels (e.g., in perimenopause) fluctuate daily, hiding the biological impact on immune function and inflammation.
2

Quantify Cumulative Hormonal Effects

Glycans provide a stable, long-term signal of the cumulative hormonal effect on the immune system and chronic inflammation.
3

Deliver Measurable, Actionable Results

Measure the shift: track the rise of pro-inflammatory glycans to get an objective metric of immune aging (inflammaging) to guide therapy.

NEXT GEN HORMONE CARE

Biomarker-Guided Hormone Optimization (BGHO)

We’re building a new clinical platform that will make BGHO possible—bringing objective, biologically anchored decision-support into hormone care.
The tool will integrate glycan-based biological age data with hormone and metabolic profiles to provide a unified picture of how therapy is influencing the body over time.
It will translate complex biomarker patterns into clear visual trajectories and actionable insights, helping clinicians see whether inflammation is resolving, biological age is improving, or risk is increasing.

OBJECTIVE HRT MANAGEMENT

Move Beyond Hormone Levels

checkmark icon Monitor the real biological response to HRT, not just hormone levels.
checkmark icon Adjust therapy based on quantitative change, not subjective feedback.
checkmark icon Communicate progress to patients through simple, evidence-driven metrics.
By embedding glycans into clinical workflows, BGHO will turn years of research into an everyday precision-medicine tool—making hormone optimization measurable, trackable, and truly personal.

STAY UPDATED

Join the Waitlist

Understand how your hormones uniquely influence inflammation, immunity and cardiovascular risk to guide personalized hormone therapies.